No public funding for the biologization of social inequality!
By Staff,
Gen-ethisches Netzwerk e.V.
| 09. 12. 2022
Statement on the objectives and use of genetic data in the Socio-Economic Panel (SOEP) of DIW Berlin (German Institute for Economic Research)
Time and again there are attempts to look to genetics to find the causes of social inequality between individuals or population groups. This erroneous focus on biology, however, paves the way for stigmatization, discrimination and violence. It is for this reason we draw attention to a new, publicly funded research project of this kind in Germany, which we believe to be in urgent need of critical monitoring by the media and the scientific community.
The Gene-SOEP project collects and analyses the genetic data of participants in a sub-group of the so-called Socio-Economic Panel (SOEP). The SOEP, or "Living in Germany", is the largest long-term study on social developments in Germany and is also one of the most comprehensive studies of this kind worldwide.
In the Gene-SOEP, genetic data of the approximately 2.600 participants are combined with demographic and social data. As a first publication of the project shows, these datasets are then used to explore the...
Related Articles
By Arthur Lazarus, MedPage Today | 01.23.2026
A growing body of contemporary research and reporting exposes how old ideas can find new life when repurposed within modern systems of medicine, technology, and public policy. Over the last decade, several trends have converged:
- The rise of polygenic scoring...
By Stephanie Pappas, LiveScience | 01.15.2026
Genetic variants believed to cause blindness in nearly everyone who carries them actually lead to vision loss less than 30% of the time, new research finds.
The study challenges the concept of Mendelian diseases, or diseases and disorders attributed to...
By David Cox, Wired | 01.05.2026
As he addressed an audience of virologists from China, Australia, and Singapore at October’s Pandemic Research Alliance Symposium, Wei Zhao introduced an eye-catching idea.
The gene-editing technology Crispr is best known for delivering groundbreaking new therapies for rare diseases, tweaking...
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...